| Literature DB >> 30871244 |
Paula Amador1, Ruben Fernandes2, Cristina Prudêncio3, Isabel Duarte4.
Abstract
The exposure of both crop fields and humans to antibiotic-resistant bacteria in animal excreta is an emergent concern of the One Health initiative. This study assessed the contamination of livestock manure from poultry, pig, dairy farms and slaughterhouses in Portugal with resistance determinants. The resistance profiles of 331 Enterobacteriaceae isolates to eight β-lactam (amoxicillin, cefoxitin, cefotaxime, cefpirome, aztreonam, ceftazidime, imipenem and meropenem) and to five non-β-lactam antibiotics (tetracycline (TET), trimethoprim/sulfamethoxazole (SXT), ciprofloxacin (CIP), chloramphenicol (CHL) and gentamicin) was investigated. Forty-nine integron and non-β-lactam resistance genes were also screened for. Rates of resistance to the 13 antibiotics ranged from 80.8% to 0.6%. Multidrug resistance (MDR) rates were highest in pig farm samples (79%). Thirty different integron and resistance genes were identified. These were mainly associated with resistance to CHL (catI and catII), CIP (mainly, qnrS, qnrB and oqx), TET (mainly tet(A) and tet(M)) and SXT (mostly dfrIa group and sul3). In MDR isolates, integron presence and non-β-lactam resistance to TET, SXT and CHL were positively correlated. Overall, a high prevalence of MDR Enterobacteriaceae was found in livestock manure. The high gene diversity for antibiotic resistance identified in this study highlights the risk of MDR spread within the environment through manure use.Entities:
Keywords: animal excreta; antibiotic-resistance genes; environmental contaminants; livestock; multidrug resistance
Year: 2019 PMID: 30871244 PMCID: PMC6466527 DOI: 10.3390/antibiotics8010023
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1Location of sampling sites depicted on (a) a map of Europe (approximate scale 1:100,000,000, (b) a map of Portugal (approximate scale 1:10,000,000) and (c) a map of Coimbra and Leiria administrative regions (dashed lines) (approximate scale 1:1,000,000). Enterprise types are represented as follows: dairy cattle farm; poultry farm; slaughterhouse; pig farm.
Animal heads per sampling site, average microbiological and physical-chemical parameters of samples.
| Characterisation of Sampling Sites | Characterisation of Samples | ||||
|---|---|---|---|---|---|
| Site Code | Enterprise Type | Animal Heads | Temperature | pH | |
| A1 | Poultry | 10,000 chicks Legorne/pavilion | 1.4 × 107 | 10.2 | 6.80 |
| A2 | Poultry | 72,000 caged laying hens Legorne | 6.9 × 109 | 24.1 | 7.24 |
| A3 | Poultry | 28,000 soil, cage-free laying hens Legorne | 7.6 × 109 | 24.0 | 7.06 |
| D1 | Dairy cattle | 100 Holstein Friesian | 1.7 × 105 | 9.4 | 8.81 |
| D2 | Dairy cattle | 30 Holstein Friesian | 5.7 × 105 | 14.6 | 7.46 |
| D3 | Dairy cattle | 54 Holstein Friesian | 2.4 × 105 | 16.9 | 8.47 |
| P1 | Pig | 48 breeding sow Large Write | 3.4 × 105 | 14.7 | 7.71 |
| P2 | Pig | 700 breeding sow, 5300 piglets Large Write | 5.0 × 105 | 14.0 | 7.16 |
| P3 | Pig | 1640 fattening pigs Large Write | 1.7 × 106 | 13.8 | 7.33 |
| S1 | Slaughterhouse | 505 piglets, 62 cattle (daily abattoir) | 1.0 × 106 | 14.1 | 6.52 |
| S2 | Slaughterhouse | 381 hogs, 740 cattle (daily abattoir) | 1.7 × 106 | 16.0 | 4.92 |
| S3 | Slaughterhouse | 190 hogs, 40 cattle (daily abattoir) | 1.1 × 109 | 23.8 | 7.31 |
Temperature (°C)—determined by thermometry; pH—determined by potentiometry.
List of AB resistance profile, AB resistance and integrons genes harboured per isolate species and sample origin.
| Sample (a) |
| Resistance Phenotype (b) | AB Resistance Genes | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMC | FOX | CTX | CAZ | CPO | ATM | IPM | MEM | CHL | CIP | GEN | SXT | TET |
|
|
|
| ||||
|
|
| x | x | x | x | x | x | x | x | - | - | A, M, L, K | 1, 2, 3 | Ia, IIb | - | |||||
|
| x | x | x | x | x | x | x | x | x | I | D, S | A, E, B, K, O | 1, 3 | Ia | - | |||||
|
| x | x | x | x | x | x | x | x | x | - | - | C | 1, 2 | Ic | - | |||||
|
| x | x | x | x | x | x | x | x | I | C, S | A | 1, 2 | Ia, IIb, IIIc | - | ||||||
|
| x | x | x | x | x | x | x | x | I | S | A, L, K | 1, 2 | Ia, Ic, IIIa, IIIc | - | ||||||
|
| x | x | x | x | - | nt | - | 3 | Ia | 1 | ||||||||||
|
| x | x | x | x | x | x | x | x | x | - | nt | A, C | 1, 2, 3 | Ia, Ib, IIIa | - | |||||
|
| x | x | x | x | x | - | nt | A, E, C, M, L | 2, 3 | Ia, IIa | - | |||||||||
|
| x | x | x | x | x | x | x | - | nt | A | 1, 3 | Ia, Ib | - | |||||||
|
| x | x | x | x | x | x | x | x | - | nt | A | 1, 3 | Ia, Ib, Ic, IIIa | - | ||||||
|
| x | x | x | x | x | - | nt | A | 2 | Ia, Ic, IIb | - | |||||||||
|
| x | x | x | x | x | x | x | - | nt | A | 3 | Ia, Ib | - | |||||||
| nt | x | x | x | x | x | x | x | x | I | S | A, M | 1, 2, 3 | Ia, IIb | - | ||||||
| nt | x | x | x | x | x | x | x | x | x | I | S | A, A(P) | 1, 3 | Ia | - | |||||
| nt | x | x | x | x | x | x | x | - | C, S | A | 1, 3 | Ia | 1 | |||||||
| nt | x | x | x | x | x | x | x | x | I | C, S | A | 1, 2, 3 | Ia | 1 | ||||||
| nt | x | x | x | x | x | x | I | B, S | A | 1, 3 | - | I | ||||||||
| nt | x | x | x | x | x | x | I | B, C, D, S | - | 1 | Ia | 1 | ||||||||
| nt | x | x | x | x | - | nt | A, A(P), M | - | IIb | - | ||||||||||
| nt | x | x | x | x | x | x | - | nt | A | - | - | - | ||||||||
| nt | x | x | x | x | x | - | B, S | A, L, K | 3 | - | - | |||||||||
| nt | x | x | x | x | x | - | B, S | A, L | 1, 3 | Ia, Ic, IIb | - | |||||||||
|
|
| x | x | x | x | x | - | nt | A | - | Ia, Ic | 2 | ||||||||
|
| x | x | x | x | x | - | A | 1, 2, 3 | Ic, IIa | - | ||||||||||
|
| x | x | x | x | x | x | x | I | B | M | 2, 3 | - | - | |||||||
| x | x | x | x | x | x | x | x | x | - | nt | A | 2 | Ia | 2 | ||||||
|
| x | x | x | x | - | nt | A, B | - | Ic | - | ||||||||||
|
| x | x | x | x | x | x | x | I | - | A | 1, 2, 3 | Ia, Ic | 1 | |||||||
|
| x | x | x | x | x | x | - | B | A | 1, 2, 3 | Ia | 2 | ||||||||
|
| x | x | x | x | x | x | - | - | - | - | Ia, IIIb | - | ||||||||
|
| x | x | x | x | x | x | x | x | I | - | B, M | 3 | Ia, IIa | 2 | ||||||
|
| x | x | x | x | x | x | x | - | B | A | - | Ia | - | |||||||
|
| x | x | x | x | x | x | x | x | x | - | B | A | - | Ia, IIIb | 1 | |||||
|
| x | x | x | x | x | x | x | x | x | - | B | A | 1, 2 | Ia, Ic | - | |||||
| nt | x | x | x | x | - | A, M | 1, 2, 3 | - | 1 | |||||||||||
| nt | x | x | x | x | x | x | - | nt | - | - | - | 2 | ||||||||
| nt | x | x | x | x | x | x | - | B, S | A | 2 | IIIb | - | ||||||||
| nt | x | x | x | x | x | x | - | nt | A, M, K | 2, 3 | - | 2 | ||||||||
| nt | x | x | x | x | x | x | - | S | A, M | 3 | - | 1 | ||||||||
| nt | x | x | x | x | x | x | x | - | nt | A | 2 | IIIb | - | |||||||
| nt | x | x | x | x | x | x | x | - | nt | A | 2, 3 | - | 1 | |||||||
|
|
| x | x | x | x | x | II | nt | A, O | 1, 2 | - | - | ||||||||
|
| x | x | x | x | x | x | x | II | nt | A, K | 1, 2 | - | - | |||||||
|
| x | x | x | x | x | x | x | I | S | A | 1, 2 | Ia | - | |||||||
|
| x | x | x | x | x | x | I | C, S | - | 1, 3 | Ia | 1 | ||||||||
|
| x | x | x | x | x | x | x | I | C, S | A | 1, 3 | Ia | 1 | |||||||
|
| x | x | x | x | x | x | x | - | nt | A | - | Ib | - | |||||||
|
| x | x | x | x | x | x | x | x | x | - | nt | A, E | 1, 3 | Ib, IIIb | - | |||||
|
| x | x | x | x | - | nt | A, E | - | Ia, Ib | - | ||||||||||
|
| x | x | x | x | - | nt | - | - | IIIc | - | ||||||||||
|
| x | x | x | x | - | nt | A | 2 | Ia, IIa | - | ||||||||||
|
| x | x | x | x | x | x | - | nt | A, E | 1 | IIc | - | ||||||||
|
| x | x | x | x | x | - | nt | - | - | Ia | - | |||||||||
| nt | x | x | x | x | x | x | - | nt | M | 3 | IIIb, IIIc | - | ||||||||
|
|
| x | x | x | - | nt | A(P), L | - | Ia, Ic | 2 | ||||||||||
|
| x | x | x | x | x | - | nt | O, M | 3 | Ia | - | |||||||||
|
| x | x | x | x | x | x | - | nt | A, M | - | Ic | - | ||||||||
|
| x | x | x | x | x | x | - | - | A, B, O, M | 3 | Ic | - | ||||||||
|
| x | x | x | x | x | x | x | x | x | - | nt | K | 1, 3 | Ia | 1 | |||||
|
| x | x | x | x | x | x | x | x | - | nt | A | 2, 3 | IIb | 1 | ||||||
|
| x | x | x | x | x | x | x | x | I | - | A, M | 2, 3 | Ic, IIb | 1 | ||||||
|
| x | x | x | x | - | nt | - | 3 | Ia, IIIb | 2 | ||||||||||
|
| x | x | x | x | x | - | - | B, M | 1, 2, 3 | Ic, IIb | - | |||||||||
|
| x | x | x | x | x | - | nt | - | - | - | - | |||||||||
|
| x | x | x | x | x | x | x | - | nt | - | 3 | IIIb | - | |||||||
| nt | x | x | x | - | nt | A(P) | - | - | 1 | |||||||||||
| nt | x | x | x | x | - | B, S | A, M | 3 | - | - | ||||||||||
| nt | x | x | x | x | x | - | B, S | B | 3 | - | - | |||||||||
| nt | x | x | x | x | x | - | nt | A, A(P), M | 3 | IIIb | 2 | |||||||||
| nt | x | x | x | x | x | - | nt | A | 1 | - | - | |||||||||
(a) Isolates origin per enterprise type: Poultry, Pig, Dairy and Slaughterhouse; (b) AB (antibiotics): AMC, amoxicillin/clavulanic acid; FOX, cefoxitin; CTX, cefotaxime; CAZ, ceftazidime; CPO, cefpirome; ATM, aztreonam; IPM, imipenem; MEM, meropenem; CIP, ciprofloxacin; GEN, gentamicin; CHL, chloramphenicol; SXT, trimethoprim/sulfamethoxazol; TET, tetracycline; nt: not tested; -: gene not present.
Figure 2Antibiotic resistance of Enterobacteriaceae isolates obtained from 12 sampling sites. Relative frequency of resistance patterns exhibited by resistant and intermediate resistant isolates to 13 AB. Tested AB: eight β-lactams: amoxicillin/clavulanic acid (AMC), ceftazidime (CAZ), cefotaxime (CTX), cefpirome (CPO), aztreonam (ATM), cefoxitin (FOX), imipenem (IPM), meropenem (MEM) and non-β-lactams: chloramphenicol (CHL), tetracycline (TET), gentamicin (GEN), trimethoprim/sulfamethoxazol (SXT) and ciprofloxacin (CIP). Enterprise type: poultry, pig, dairy, slaughterhouse.
Figure 3Relative frequency of the number of antibiotics to which each isolate resists. Enterprise type: poultry, pig, dairy, slaughterhouse.
Absolute and relative frequency of isolates with cat, qnr, oqx, aac(6’)-Ib, qep, tet, sul, dfr and intI genes per enterprise type.
| Target Gene/Group | Enterprise Type | Total * | ||||
|---|---|---|---|---|---|---|
| Poultry * | Pig * | Dairy * | Slaughterhouse * | |||
|
| I | 8 (36.4) | 3 (15.7) | 3 (23.1) | 1 (6.3) | 15 (21.4) |
| II | 2 (15.4) | 2 (2.9) | ||||
| III, IV | 0 (0.0) | |||||
|
| A | 0 (0.0) | ||||
| B | 4 (30.8) | 6 (50.0) | 2 (40.0) | 12 (36.4) | ||
| C | 4 (30.8) | 2 (66.7) | 6 (18.1) | |||
| D | 2 (15.4) | 2 (6.1) | ||||
| S | 11 (84.6) | 2 (16.7) | 3 (100.0) | 2 (40.0) | 18 (54.6) | |
|
| A | 0 (0.0) | ||||
| B | 2 (16.7) | 2 (6.1) | ||||
| 0 (0.0) | ||||||
|
| A | 0 (0.0) | ||||
|
| A | 19 (86.4) | 15 (78.9) | 9 (69.2) | 7 (43.8) | 50 (71.4) |
| B | 1 (4.6) | 2 (10.5) | 3 (18.8) | 6 (8.6) | ||
| C | 3 (13.6) | 3 (4.3) | ||||
| E | 2 (9.1) | 3 (23.1) | 5 (7.1) | |||
| K | 4 (18.2) | 1 (5.3) | 1 (7.7) | 1 (6.3) | 7 (10.0) | |
| L | 5 (22.7) | 1 (6.3) | 6 (8.6) | |||
| M | 4 (18.2) | 5 (26.3) | 1 (7.7) | 7 (43.8) | 17 (24.3) | |
| O | 1 (4.6) | 1 (7.7) | 2 (12.5) | 4 (5.7) | ||
| A(P) | 2 (9.1) | 3 (18.8) | 5 (7.1) | |||
| D, G, S, Q, X | 0 (0.0) | |||||
|
| 1 | 15 (68.2) | 5 (26.3) | 7 (53.8) | 3 (18.8) | 30 (42.9) |
| 2 | 9 (40.9) | 11 (57.9) | 4 (30.8) | 3 (18.8) | 27 (38.6) | |
| 3 | 15 (68.2) | 9 (47.4) | 4 (30.8) | 11 (68.8) | 40 (57.1) | |
|
| Ia | 17 (77.2) | 9 (47.4) | 6 (46.2) | 4 (25.0) | 36 (51.4) |
| Ib | 4 (18.2) | 3 (23.1) | 7 (10.0) | |||
| Ic | 5 (22.7) | 5 (26.3) | 5 (31.3) | 15 (21.4) | ||
| IIa | 1 (4.6) | 2 (10.5) | 1 (7.7) | 4 (5.7) | ||
| IIb | 6 (27.3) | 3 (18.8) | 9 (12.9) | |||
| IIc | 1 (7.7) | 1 (1.4) | ||||
| IIIa | 3 (13.6) | 3 (4.3) | ||||
| IIIb | 4 (21.1) | 2 (15.4) | 3 (18.8) | 9 (12.9) | ||
| IIIc | 2 (9.1) | 2 (15.4) | 4 (5.7) | |||
| IVa, IVb, IVc | 0 (0.0) | |||||
| Va, Vb, Vc, Vd | 0 (0.0) | |||||
|
| 1 | 5 (22.7) | 5 (26.3) | 2 (15.4) | 4 (25.0) | 16 (22.9) |
| 2 | 6 (31.6) | 3 (18.8) | 9 (12.9) | |||
| 3 | 0 (0.0) | |||||
* n (%), absolute and (relative) frequency of isolates carrying the gene. The blank space means a negative result, i.e., 0 (0%).
Resistance phenotype of isolates from four livestock enterprises to non-β-lactamic AB and corresponding presence of integrons class.
| AB | Resistant Isolates (N) | Resistant Isolates with Integrons, N (%) | Resistant Isolates without Integrons, N (%) | |
|---|---|---|---|---|
| CHL | 58 | 14 (24.1%) | 8 (13.8%) | 36 (62.1%) |
| CIP | 29 | 10 (34.5%) | 1 (3.4%) | 18 (62.1%) |
| GEN | 7 | 1 (14.3%) | 0 (0.0%) | 6 (85.7%) |
| SXT | 56 | 15 (26.8%) | 8 (14.3%) | 33 (58.9%) |
| TET | 63 | 13 (20.6%) | 8 (12.7%) | 42 (66.7%) |
N (%), absolute and (relative) frequency of isolates carrying the gene.